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One of the causes of injury to the elderly is due to falls. Falling can be 
prevented by identifying and controlling risk factors. One risk factor that can 
be controlled is the use of fall risk medicines including psychoactive. This 
study aims to identify the association between the use of psychoactive 
medicine and its characteristic with the risk of falls among the elderly in 
Indonesia.  The study utilized a case-control study design for a total number 
of 414 elderly patients, during October until December 2018. Cases were 
elderly aged 60 years or above with a high risk of falling assessed using the 
Morse Fall Scale (MFS≥45). Each case was matched with up to two randomly 
selected controls of the same age who are classified as low to moderate risk 
of falling (MFS<45). The use of psychoactive medicines was screened from a 
history of drug use for the past six months. Psychoactive medicine-fall risk 
associations were estimated via logistic regression. There were 138 cases and 
276 controls. The median age of subjects was 66 years old and 54.83% was a 
woman. Elderly with a high risk of falling had higher psychoactive medicines 
use when compare with controls (31.16 % vs 21.38 %, p< 0.05). After 
adjusting for potential confounders, the use of psychoactive medicines was 
significantly associated with higher fall risk in elderly patients (OR 1.79 95% 
CI 1.10-2.90). Only the duration of psychoactive medication use over 90 days 
was significantly associated with a high risk of falling (AOR 3.65 95% CI 1.46-
9.14). In elderly patients, the continued use of psychoactive medicines 
increased the risk of fall. Prescribers need to weigh risk and benefit from the 
use of psychoactive medicines in the elderly to prevent future fall.  
Keywords: Psychoactive medicine, fall risk, elderly, patients.  
 
 
INTRODUCTION  
The Indonesian elderly population rate is 
increasing every year. The proportion of the elderly 
population was 9.77% in 2010 and predicted to 
increase to 11.34% to 21.4% within 2020 and 2050 
(Ministry of Health Republic of Indonesia, 2014). 
The steep increase in the elderly population is a 
general health concern because this is a population 
where multiple chronic diseases and problems are 
commonly found and usage of medicines is at the 
highest rate. One of the important health problems 
commonly found in an older person is fall. The 
incidence of falls per year in elderly ≥64 years is  
28-35%, whereas elderly ≥70 years is 32-42%. Fall 
caused serious injury that occurred in 47.7 per 
1000 populations (Yoshida, 2007). Fall in the 
elderly is considered as a major health problem 
because it can lead to morbidity and mortality 
(Grundstrom et al., 2013). Fall can be prevented by 
identifying and controlling fall risk factors. There 
are   multiple   risk   factors   such as   intrinsic  and 
extrinsic factors which can contribute to the 
increment of falls rates. Medication use is 
categorized as an extrinsic factor for fall in older 
people (CDC, 2017; WHO, 2007). One of the fall risk 
medicines is psychoactive medicines. Psychoactive 
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medicines are substances that can alter mood, 
thought processes, or behavior by causing sedation, 
hypnosis and muscle relaxation (Lindsey, 2009). 
Studies have shown that psychoactive medicines 
with sedative property can cause an adverse effect 
such as fall (Woolcott et al., 2009) by acting on the 
central nervous system. In addition, the elderly 
patient had increased blood-brain barrier 
permeability and receptor sensitivity to 
psychoactive medicines (Lee et al., 2016). The 
previous study in Germany revealed that 
psychoactive drug use was associated with falls in 
the elderly with OR 1.64 (95% CI 1.14-2.37) (Du et 
al, 2017). Another study updated meta-analysis 
study of psychoactive drugs use and falls in the 
elderly with OR 1.78 (95% CI 1.57- 2.01) (Bloch et 
al., 2011). However, the study of psychoactive 
medication use related to fall risk is limited among 
Indonesian elderly. Therefore, this study was 
aimed to identify the association between the use 
of psychoactive medicine and its characteristic 
with the risk of falls among the elderly in Indonesia.   
  
MATERIAL AND METHODS 
Study design and subjects 
This study was a retrospective case-control 
study that involved elderly outpatient attending 
internal medicine and neurology outpatient clinics 
at two regional general hospitals (RSUD dr. 
Soedono Madiun and RSUD Kota Madiun) in 
Madiun city, Indonesia, during October until 
December 2018.  A number of 414 elderly patients 
were involved in this study with the consent given. 
Cases were elderly aged 60 years or above with a 
high risk of falling assessed with the Morse Fall 
Scale (MFS≥45), while controls were elderly with 
low to moderate fall risk (MFS <45). The Morse fall 
Scale is a tool to measure fall risk by means 
interviews and observations. The MFS was widely 
used to asses fall risk in patients (Blalock, 2016).  In 
Indonesia, MFS also widely used in practice and in 
research (Anto, 2015; Lestari, 2015). It is more 
sensitive than another instrument (Dessy et al., 
2013). It consists of six item questions with scoring 
between 0 and 125 points. The scoring is divided 
into three, categorized as follows: scoring between 
0 and 24 points are at low risk of falls, scoring 
between 25 and 44 points are at moderate risk of 
falls and, scoring with 45 points or more are at high 
risk of falls. Patients classified as high risk were 
considered exposed to falls (MFS score of 45 or 
higher), while low and moderate risk patients (MFS  
 
between 0-44) were considered not exposed to the 
event (Costa-Dias et al., 2014; Pasa et al., 2017).  
The fall risk assessed when they revisit to 
hospitals on October-Decembers 2018. The control 
patients were randomly matched according to age 
with cases for up to two controls. The history of 
drugs used and comorbidity were examined and 
extracted from the medical record. While the use of 
psychoactive medicines was screened from a 
history of drug use for the past six months. The 
inclusion criteria in this study were age ≥60 years, 
neurology clinic patients who made return visits, 
patients without physical disabilities, able to 
communicate, willing to be participants, complete 
medical records. Elderly patients were excluded if 
they underwent orthopedic surgery, patients with 
neurocognitive disorders, and they did not have 
medical records at pharmacy installations.                       
The Medical and Health Research Ethics  
Committee (MHREC) of Gadjah Mada University's 
Faculty of Medicine approved this study 
(KE/KF/1116/EC/2018).  
 
Characteristics of participant 
The participant was interviewed to fill out 
the sociodemographic data form. Data on age, 
gender, height, and weight were collected. The ages 
were categorized into 3 groups based on BPS-
Statistics Indonesia categorical, 60-69 years, 70-79 
years, and ≥80 years (Badan Pusat Statistik, 2018). 
Body Mass Index (BMI) is calculated from the ratio 
of body weight (kg) to the square of the height 
(m2), and categorized into normal (<25kg/m2), 
and abnormal (≥25kg/m2) (WHO, 2018a). The 
comorbid were assessed from the medical record.  
It was scored using the Charlson Comorbidity  
Index (CCI) (Chan et al., 2014). Otherwise, the use 
of non-psychoactive medicine related to falls was 
scored using the Medication Fall Risk Score 
(MFRS). The non-psychoactive fall risk drugs are 
Antihypertensive, Cardiac Drugs, Antiarrhythmics, 
and Diuretics (Ganz et al., 2013).  
 
The characteristics of psychoactive drugs use 
Psychoactive drugs defined based on the 
classification WHO of Anatomical Therapeutic 
Chemical (ATC). These drugs involved Opioid 
Analgetic (N02A), Antimigraine (N02C), 
Antiepileptic (N03), Antiparkinson (N04), 
Antipsychotics (N05A), Anxiolytic (N05B), 
Hypnotic-sedatives (05C), and Antidepressants 
(N06A)  (Pratt  and  Ramsay,  2014;  WHO,  2018b).  
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Participants were categorized into using 
psychoactive medicine if they use the medication 
with the refill adherence ≥100%. The refill 
adherence defined as the percentage of a number   
of prescribed treatment days divide number                  
days between fills (Andersson et al., 2005).  
Anyway, a participant that did not take the 
medication for 3 days or less also included in this 
group as they still in the wash-out period (Shuto et 
al., 2010). The characteristics of psychoactive 
medicine that evaluate in the study included the 
duration of drug use, the number of psychoactive 
drugs, and The Standardized Daily Dose (SDD). The 
duration of drug use was grouped into 1-30 days, 
31-90 days, and >90 days. This category based on 
the insurance policy for the chronic disease patient 
will receive the medicine periodically every 30 
days (Ministry of Health Republic of Indonesia, 
2016). The chronic disease usually needs 
medication over 90 days or longer (National Health 
Council, 2016). The number of psychoactive                
drug use are grouped into using 1 psychoactive 
medicine and ≥2 psychoactive medicines. While  
the Standardized Daily Dose (SDD) was the ratio              
of daily dose to DDD (Defined Daily Dose) (Pratt 
and   Ramsay,  2014).  The   SDD  was  grouped  into               
0.1-0.5DDD/day, and >0.5DDD/day. It’s based on 
an earlier study that mostly patient (98%) were 
had SDD <1 DDD/days. 
 
Statistically analysis 
Statistically, the analysis was performed 
using the Statistical Package for the Social Sciences 
(SPSS) software. The categorical data were 
analyzed using the Chi-square test and the 
association analysis between independent and 
dependent variables was derived from logistic 
regression. P value was accepted as statistically 
significant if p<0.05. In this study, the confounding 
factors were age, gender, BMI, comorbidity (CCI) 
and the use of nonpsychoactive medicine related to 
falls (MFRS). The confounding factor controlled by 
statistical analysis. 
 
RESULT AND DISCUSSION 
There are two fall risk factors, intrinsic 
factors, and extrinsic factors. Intrinsic factors were 
demographic factors (race, and socioeconomic 
status) and biological factors (age, sex, medical 
conditions/comorbidity, and physical condition’s 
example body mass index). Extrinsic factors were 
medication intake almost psychoactive drugs, 
alcohol  misuse,  and  inappropriate shoes (Yoshida,  
2007). In this study, the risk factor for falling as an 
independent variable was psychoactive drug use, 
while other risk factors were confounding factors. 
The confounding can be seen as the characteristics 
of participants (Table I). 
 
Characteristics of participant 
There were 414 elderly patients involved in 
the study. Where 138 were cases and 276 were 
controls. The highest percentage 62.56% (259) of 
patients was between 60 - 69 years old. In the study 
entry, the median age of patients was 66 years old 
with range 60 until 90 years old. This is in line with 
the results of the census of BPS-Statistics Indonesia 
in 2017 that Indonesian elderly population was 
dominated (63%) by aged 60-69 years (young 
elderly) (Table I) 
On 54.83% of participants in this study were 
female and dominated by low comorbidiy 
(Charlson Comorbidity Index 0-1). This is in line 
with the result of the census of BPS-Statistic 
Indonesia that elderly population in 2017 was 
dominated by female 52,52%. The female elderly 
patient had longer life expectancy because                     
they had greater awareness of health condition           
and treatment (Badan Pusat Statistik,  2018). 
Meanwhile, the body mass index of the participants 
was dominated (75.85%) by normal (BMI<25)             
(Table I). Characteristics of participants showing 
that the case group was similar to the control group 
in age, gender, BMI and MFRS (p>0.05), except that 
the case group was more likely to have higher 
comorbidity index (Table I).  
 
Description of fall risk 
The study revealed the fall risk in elderly 
patients in Indonesia had an average of 
29.03±26.67 (moderate fall risk). This is in line 
with the results of studies in the Brazilian elderly. 
They had moderate fall risk with mean MFS of 
39.4±19.4 (Pasa et al., 2017).  
The description of fall risk in participants 
(Table II) shows that female participants and 
participants with BMI ≥25 kg/m2 had higher fall 
risk. The fall risk also increased with age until           
80 years old and then began to decrease. It may be 
due to proportion of elderly patients ≥80 years            
old was small. The study in line with studies 
conducted by Alshammari et al. (2018) and Yoshida 
(2007) revealing that the fall risk was influenced  
by intrinsic risk factors such as age, sex,          
physical condition (body mass index) and health 
conditions. 
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The characteristics of psychoactive drugs use 
Table III shows the use of psychoactive 
medicines in elderly patient by 102 (24.64%.). Such 
numbers was smaller than in the previous study, or 
33.6% in the Brazilian elderly population (Cabrera 
et al., 2010). The most psychoactive medicines  
used by participant were Gabapentin (17.39%), 
Diazepam (10.87%), and Amitriptyline (8.70%) 
(Table IV). The use of psychoactive medicines in the 
case group was statistically and significantly higher 
than that in the control group (31.16% vs 21.38%, 
p<0.05) (Table III). This is consistent with the 
finding of the previous study in Germany revealing 
that the elderly with fall had higher psychoactive 
drugs use (33.1% vs. 20.7%) (Du et al., 2017). The 
characteristics of psychoactive medicines evaluated 
in the study were duration of drug use, the number 
of psychoactive drugs, and The Standardized          
Daily Dose (SDD). (Table III). The Standardized 
Daily   Dose  (SDD) >0.5DDD/day,   the   number  of  
psychoactive≥2 and duration of use >30 days in the 
case group were statistically and significantly 
higher than that in the control group (p<0.05). 
Therefore, they could be candidates to multiple 
logistic regression analysis (p<0.25) to derive the 
influential variables to fall risk. 
 
Association Psychoactive drugs use and fall risk 
Overall, this study found that the use                        
of psychoactive medicines was associated with          
risk of falls (Table V). The use of psychoactive 
medicines would increase 1.79 times of the risk                
of falls higher than   patients who  did not use           
(95% CI 1.10-2.90). These results were consistent 
to previous  studies (Bloch et al., 2011;                           
Du et al., 2017; Mustafidah, 2019). A Study 
conducted in  Germany elderly population in                
2008-201 revealed that psychoactive drug use              
was associated with falls in the elderly                                
with OR  1.64  (95% CI   1.14-2.37)  (Du et al.,  2017).  
  
Table I. Description of the characteristics of the study participants 
 
Sociodemography 
Total N=414 Case (MFS≥45) n=138 Control (MFS<45) n=267 
P 
n % n % n % 
Age (years) 
≥80 31 7.49% 10 7.25% 21 7.61% 
0.085 70-79 124 29.95% 51 36.96% 73 26.45% 
60-69 259 62.56% 77 55.80% 182 65.94% 
Gender 
Female 227 54.83% 75 54.35% 152 55.07% 
0.972 
Male 187 45.17% 63 45.65% 124 44.93% 
Body Mass Indexs 
≥25 100 24.15% 41 29.71% 59 21.38% 
0.081 
<25 314 75.85% 97 70.29% 217 78.62% 
Charlson  
Comorbidity Index 
(CCI) 
≥2 148 35.75% 35 25.36% 113 40.94% 
0.001 1 210 50.72% 87 63.04% 123 44.57% 
0 56 13.53% 16 11.59% 40 14.49% 
Non-psychoactive  
Fall Risk Drugs in  
MFRS 
≥4 97 23.43% 29 21.01% 68 24.64% 
0.274 1-3 109 26.33% 43 31.16% 66 23.91% 
0 208 50.24% 66 47.83% 142 51.45% 
 
The analysis using Chi Square test, number in bold are stastistically significant 
 
Tabel II. Description of the risk of falls in the study participants  
 
Characteristics Fall Risk (MFS) (Mean±SD) 
Age (years) 
≥80 29.84±26.31 
70-79 32.58±27.35 
60-69 27.24±26.30 
Gender 
Female 30.00±27.00 
Male 27.86±26.28 
Body Mass Index (BMI) (Kg/m2) 
≥ 25 33.15±26.92 
<25 27.72±26.49 
Mean ± SD   29.03±26.67 
 
SD: Standard Deviation 
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Another study updated meta-analysis study of 
psychoactive drugs use and falls in the elderly with 
OR 1.78 (95% CI 1.57- 2.01) (Bloch et al., 2011). 
The only characteristic of psychoactive drug use 
associated with fall risk was duration of drug use 
over 90 days, with an Adjusted Odd Ratio of 2.76 
(95% CI 1.15-6.64) (Table V). Compared to other 
studies, this study investigated the duration of drug 
use for six month only, while the study conducted 
by Hanlon et al (2009) assessed the psychoactive 
drug use for longer duration  (5 years). This          
study stated that psychoactive drug use in short 
term <2 years had 1.49 times fall risk higher than 
those who did not use (adjusted OR 1.49 95% CI 
1.11-2.01). The number and dosage of psychoactive 
medicines (SDD) did not have association with risk 
of fall, so that it was not consistent with the 
previous study. Pratt and Ramsay’s study in 2014 
showed a significantly increased risk of falls when 
using one or more psychoactive medicines in             
Tabel III. Characteristics of psychoactive drugs use in case group and control group 
 
Characteristic Category 
Group 
p Total 
Case (MFS≥45)  
n=138 
Control (MFS<45) 
 n=276 
n % n % n % 
Psychoactive  
Drugs use 
Use 102 24.64% 43 31.16% 59 21.38% 
0.040 
No Use 312 75.36% 95 68.84% 217 78.62% 
Doses 
>0.5 DDD/day 16 3.86% 10 7.25% 6 2.17% 
0.016 
0.1-0.5 DDD/day 86 20.77% 33 23.91% 53 19.20% 
Duration  
>90 days 31 7.49% 21 15.22% 10 3.62% 
0.000 31-90 days 17 4.11% 9 6.52% 8 2.90% 
1-30 days 54 13.04% 13 9.42% 41 14.86% 
Number 
>=2 drugs 49 11.84% 30 21.74% 19 6.88% 
0.000 
1 drug 53 12.80% 13 9.42% 40 14.49% 
 
The analysis using Chi Square test, Number in Bold is stastistically significant. 
 
Tabel IV. Description of psychoactive drugs use by study participants 
 
No ATC Name of Drugs n (%) 
1 N03AX12 GABAPENTIN 72 (17.39%) 
2 N05BA01 DIAZEPAM 45 (10.87%) 
3 N06AA09 AMITRIPTYLINE 36 (8.70%) 
4 N04AA01 TRIHEXYPENIDIL 9 (2.17%) 
5 N04BA02 LEVODOPA + BENZERAZIDE 9 (2.17%) 
6 N02AX02 TRAMADOL 5 (1.21%) 
7 N03AB02 PHENYTOIN 3 (0.72%) 
8 N05AD01 HALOPERIDOL 3 (0.72%) 
9 N05BA12 ALPRAZOLAM 2 (0.48%) 
10 N03AA02 PHENOBARBITAL 2 (0.48%) 
 
Tabel V. Association of psychoactive drugs use and their characteristics with risk of falls  
 
Psychoactive 
Unadjusted Adjusted 
OR Lower Upper OR Lower Upper 
Psychoactive drugs use Use 1.66 1.05 2.64 1.79 1.10 2.90 
Doses >0,5 DDD/day 3.81 1.35 10.78 NS 
Duration  >90 days 4.80 2.18 10.58 3.65 1.46 9.14 
Number >=2 drugs 3.61 1.93 6.73 NS 
 
The analysis using Binary Logistic Regression Test with Backward LR Method, Number in bold are stastistically 
significant, NS: Non-Statistically Significant. Adjusted: to age, body mass index, and Charlson Comorbidity Index 
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0.1-0.9DDD/day or more. This phenomenon was 
due to changes of pharmacokinetics and 
pharmacodynamics of the drugs in elderly patients. 
The pharmacokinetics changes include increasing 
of volume distribution of lipid soluble drugs like 
psychoactive, reduction in hepatic clearance,  and 
also renal clearance, so that it prolongation  
elimination half-life. Meanwhile pharmacodynamic 
changes increase sensitivity of the central nervous 
system as the effects of psychoactive medicines 
(Lee et al., 2016). These explained that the use of 
psychoactive medicine in Indonesian elderly was 
one or more ,but the Standardized Daily Doses 
(SDD) was low (0.1-0.5DDD/day). However, the 
potential risk of falls would increase if they used 
drugs in long term. In this case, the psychoactive 
medicine will have accumulate, stay longer in the 
body, and make undesirable effects to the central 
nervous system in elderly patients (Mangoni and 
Jackson, 2003). 
 The results of this study indicated that the 
use of psychoactive medicine in the elderly needs 
more attention. To prevent the occurrence of falls 
in elderly patients, patients and families must be 
educated about the risk of falling and health 
professional must collaborate to minimize the use 
of these drugs by taking their risks and benefits into 
consideration (Ganz et al., 2013; WHO, 2007). The 
confounding factors in this study that needs to be 
controlled were age, body mass index, and 
comorbidity (p<0.25) (Table I). The result of 
multivariate analysis using binary logistic 
regression revealed that the confounding factors 
significantly influenced to fall risk was age 70-79 
years old with OR 1.83 (95%CI 1.13-2.94). This 
result was in line with previous studies that age 70-
79 years old had an odd ratio (OR) 1.36 (95% CI 
1.08-1.72) (Gale et al., 2016). In this study, the age 
of ≥80 years old was not statistically significantly 
influence to fall risk. It may be due to the 
proportion of elderly patients ≥80 years old was 
small.  There was a number of strengths of this 
study such as an adequate sample of elderly 
patients in two secondary hospitals involved in this 
study.  We also adjusted to potential confounding 
factors for falls including age, gender, BMI, 
comorbidity, and use of non-psychoactive medicine 
(MFRS). However, this study have limitations,  we 
did not adjust to other potential risk factors for falls 
such as visual impairments, habit of using 
footwear, and influence of using non-psychoactive 
drugs such as nonsteroidal anti-inflammatory 
drugs (NSAIDS), Antihistamine, and  Hypoglycemic  
agents that were not in the list of Medication Fall 
Risk Score (MFRS) (Berlie & Garwood, 2010; WHO, 
2007). Therefore, it is expected that they could be 
analyzed in the future studies. 
 
CONCLUSION 
In elderly patients, the use of psychoactive 
medicines and continued use of its increased the 
risk of fall. Therefore, prescribers need to weigh 
risk and benefit from the use of these medicines in 
the elderly to prevent future fall. 
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